ALK rearrangement in a large series of consecutive non-small cell lung cancers: comparison between a new immunohistochemical approach and fluorescence in situ hybridization for the screening of patients eligible for crizotinib treatment.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Echinoderm microtubule associated proteinlike 4-anaplastic lymphoma receptor tyrosine kinase (EML4-ALK) translocation has been described in a subset of patients with non-small cell lung cancer (NSCLC) and has been shown to have oncogenic activity. Fluorescence in situ hybridization (FISH) is used to detect ALK-positive NSCLC, but it is expensive, time-consuming, and difficult for routine application.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Arch. Pathol. Lab. Med.

Title: Archives of pathology & laboratory medicine

ISSN (Electronic): 1543-2165

ISSN (Print): 0003-9985

Publication date (Electronic): Nov 2014

Volume: 138

Issue: 11

Affiliations

[1 ] From the Units of Pathological Anatomy (Drs Alì, Proietti, Lupi, and Sensi and Ms Pelliccioni), Pneumology (Dr Chella), Endoscopic Section of Pneumology (Dr Ribechini), and Thoracic Surgery (Drs Melfi and Lucchi), Azienda Ospedaliera Universitaria Pisana, Pisa, Italy; the Units of Pathological Anatomy (Ms Niccoli and Drs Giannini, Borrelli, and Fontanini) and Thoracic Surgery (Dr Mussi), Department of Surgical, Medical, Molecular Pathology and Critical Area, University of Pisa, Pisa, Italy; Diatech Pharmacogenetics, Jesi, Italy (Dr Menghi); and the Department of Oncology, Istituto Toscano Tumori, Ospedale Civile, Livorno, Italy (Dr Cappuzzo).

Article

DOI: 10.5858/arpa.2013-0388-OA

PubMed ID: 24885803

SO-VID: 018c898b-a966-4c1b-9cb2-18b076a71aa6

History

Data availability:

Comments

Comment on this article

scite_

Cited by 23

See all cited by